Ethyl acetate extract from Platycladus orientalis leaves ameliorates diabetic cardiomyopathy via alleviating oxidative stress and suppressing myocardial fibrosis
Frontiers in Pharmacology · 13.05.2026 · 17
DOI: 10.3389/fphar.2026.1771512 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 13.05.2026. Verfasst von Chao Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of CT, Rizhao People's Hospital, Rizhao, Shandong, China. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Health of Shandong Province.
Abstract (Originalsprache)
Introduction
Diabetic cardiomyopathy (DCM) remains a serious clinical challenge with limited effective therapeutic options. This study investigated the cardioprotective effects and underlying mechanisms of ethyl acetate extract from Platycladus orientalis leaves (EAEPOL) in a murine DCM model.
Methods
C57BL/6 mice were randomized into control, DCM, and EAEPOL treatment groups. The chemical constituents of EAEPOL were identified by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Random blood glucose levels were monitored longitudinally throughout the intervention. Cardiac function, myocardial fibrosis, oxidative stress, endothelial integrity markers and fibrosis-related markers were assessed comprehensively. The Nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) pathway was analyzed by Western blot and quantitative Reverse Transcription polymerase chain reaction (qRT-PCR).
Results
LC-MS/MS identified 60 compounds in EAEPOL, with ginkgetin, cyanin, myricitrin, and amentoflavone exhibiting relatively high contents. Compared with the control group, DCM mice exhibited marked and persistent hyperglycemia, significant cardiac dysfunction, myocardial fibrosis, and oxidative stress and disrupted endothelial/fibrotic marker expression ( P < 0.05, P < 0.01, P < 0.001 or P < 0.0001). Compared with the DCM group, EAEPOL treatment significantly lowered random blood glucose levels in a time-dependent manner, improved cardiac function, reduced fibrosis, enhanced antioxidant capacity, modulated Nrf2/HO-1 signaling, and restored endothelial/fibrotic marker expression ( P < 0.05, P < 0.01, P < 0.001 or P < 0.0001).
Conclusion
EAEPOL exerts significant protective effects against DCM via reducing hyperglycemia, Nrf2/HO-1-mediated antioxidant responses and suppression of myocardial fibrotic remodeling. These findings suggest that EAEPOL represents a potential natural cardioprotective agent for DCM that warrants further preclinical investigation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of CT, Rizhao People's Hospital, Rizhao, Shandong, China.
- College of Pharmacy, Jining Medical University, Rizhao, China.
Förderung
- Department of Health of Shandong Province
Zitieren
APA
Wang, C., Sun, Y. X., Guo, J. H., Shen, X. W., & Li, L. (2026). Ethyl acetate extract from Platycladus orientalis leaves ameliorates diabetic cardiomyopathy via alleviating oxidative stress and suppressing myocardial fibrosis. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1771512
Vancouver
Wang C, Sun YX, Guo JH, Shen XW, Li L. Ethyl acetate extract from Platycladus orientalis leaves ameliorates diabetic cardiomyopathy via alleviating oxidative stress and suppressing myocardial fibrosis. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1771512
BibTeX
@article{Wang2026,
author = {Wang, Chao and Sun, Yi-Xuan and Guo, Jia-Hui and Shen, Xin-Wei and Li, Li},
title = {Ethyl acetate extract from Platycladus orientalis leaves ameliorates diabetic cardiomyopathy via alleviating oxidative stress and suppressing myocardial fibrosis},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1771512}
}
EUVIMED